Follow the TC BioPharm (Holdings) plc share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). The latest transaction was filed on 11 January 2023 (Acquisition). Among the most active insiders: Randall Kenneth Edward. All data is openly available.
7
Insider Decl.
n/a
Thresholds
€2m
7 ops.
Buy Volume
n/a
n/a
Sell Volume
32Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
20,803 shares@ US$1.153.2% of flowOrdinary Shares [ADS]SEC:0001929926-22-000002:0
Canonical exit: 22 Aug 2022 (T+90)
7 of 7 declarations
Acerca de TC BioPharm (Holdings) plc
TC BioPharm (Holdings) plc es una empresa biofarmacéutica centrada en el desarrollo de terapias celulares para el tratamiento del cáncer y otras enfermedades. Cotiza en NASDAQ.